{"id":"W2139468685","doi":"10.1093/annonc/mdt201.8","title":"Regard Phase 3, Randomized Trial of Ramucirumab in Patients with Metastatic Gastric or Gej Adenocarcinoma Following Progression on First-Line Chemotherapy","year":2013,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Gastric Cancer Management and Outcomes","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"ca_institutions":"Hôpital Notre-Dame","funders":"","keywords":"Medicine; Ramucirumab; Internal medicine; Hazard ratio; Clinical endpoint; Progression-free survival; Oncology; Cancer; Gastroenterology; Bevacizumab; Placebo; Phases of clinical research; Chemotherapy; Randomized controlled trial; Confidence interval; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061724,0.0001841178,0.001402236,0.000393632,0.0000238553,0.000005415376,0.0001092372,0.00007006744,0.0003096771],"category_scores_gemma":[0.0003764052,0.0001088784,0.0002361927,0.0003943237,0.00009802827,0.00008591121,0.00002875881,0.0001306607,0.00000541176],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004846486,"about_ca_system_score_gemma":0.0001155945,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000859875,"about_ca_topic_score_gemma":0.00002783838,"domain_scores_codex":[0.9982095,0.0001670535,0.0007225813,0.000236995,0.0003801636,0.0002836704],"domain_scores_gemma":[0.9985624,0.0004423518,0.0005029872,0.0002548427,0.0001560156,0.00008140192],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8509658,0.003631389,0.01900779,0.0001140296,0.0004251956,0.00003766958,0.0001990073,0.000008092677,0.000007878855,0.00001280943,0.001592501,0.1239978],"study_design_scores_gemma":[0.9405789,0.03835128,0.01925815,0.0002301879,0.0002552938,0.000001805927,0.00005598417,0.00009979191,0.0002697202,0.00006010165,0.0007452948,0.00009344246],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9916017,0.0001255878,0.00008567429,0.003272963,0.0001578671,0.004075873,0.000002969415,0.00001503159,0.0006623365],"genre_scores_gemma":[0.9973701,0.0001157781,0.001252412,0.0006828923,0.0000525472,0.0002180682,0.00002820784,0.00002063323,0.0002593846],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1239044,"threshold_uncertainty_score":0.4439933,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05884592573580101,"score_gpt":0.3884167843187075,"score_spread":0.3295708585829065,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}